openPR Logo
Press release

Psychedelic Drugs Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities

05-14-2025 12:03 PM CET | Health & Medicine

Press release from: The Business Research Company

Psychedelic Drugs Market Share

Psychedelic Drugs Market Share

The Psychedelic Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Psychedelic Drugs Market Size and Projected Growth Rate?
The market size of psychedelic drugs has seen substantial expansion in the previous years. The forecast suggests an increase from $5.56 billion in 2024 to $6.39 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 14.9%. Factors contributing to the growth during the historical period include evolving regulatory dynamics, heightened consciousness of mental health, and variations in the public's viewpoint.

In the upcoming years, the market size of psychedelic drugs is projected to witness swift expansion. The market is anticipated to reach a value of $11.93 billion in 2029, indicating a compound annual growth rate (CAGR) of 16.9%. The increase in the forecasted period can be credited to the progress in the development of drugs, the broadening of therapeutic uses, increasing recognition in the medical fraternity, policy alterations, and efforts to tackle the mental health crisis. Key trend forecasts for the period include emphasis on education and public awareness, legislative and regulatory alterations, diversification of psychedelic substances, and emphasis on patient-oriented treatment strategies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6345

What Are the Major Segments in the Psychedelic Drugs Market?
The psychedelic drugs market covered in this report is segmented -

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia
2) By Disease Indication: Depression, PTSD
3) By Origin: Natural, Synthetic
4) By Application: Treatment-Resistant Depression, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders
5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:
1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters
2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable
3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid
4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules
5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

What Are The Driving Psychedelic Drugs Market Evolution?
The escalation in instances of mental health disorders is projected to drive the advancement of the psychedelic drugs market in future. These disorders, characterised by alterations in emotions, thought processes, or behaviours, encompass conditions like distress and post-traumatic stress disorder. Psychedelic drugs, commonly used for treating depression and PTSD, help in curbing these mental health issues when used regularly. For instance, as per the National Centre for Social Research, a social research institute in the UK, the percentage of 17-to 19-year-olds suspected of having a mental disorder surged from 17.4% in 2021 to 25.7% in 2022. Consequently, the rising prevalence of mental health disorders is fueling the expansion of the psychedelic drugs market.

Which Firms Dominate The Psychedelic Drugs Market Segments?
Major companies operating in the psychedelic drugs market include Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation, Beckley Psytech, Awakn Life Sciences, Psygen Industries, Enveric Biosciences, Filament Health, Tactogen, Bexson Biomedical, BetterLife Pharma, Clairvoyant Therapeutics, Universal Ibogaine

What Trends Are Driving Growth in The Psychedelic Drugs Market?
Leading firms in the psychedelic drugs market are prioritizing the development of pioneering products like ketamine to bolster therapeutic results for mental health disorders, increase patient access to treatments, and probe into new uses for psychedelic compounds in fields such as depression, anxiety, PTSD, and substance abuse disorders. Ketamine, an anesthetic and analgesic medication popular for its dissociative characteristics, is currently being investigated for its speedy antidepressant impacts in managing serious depression and PTSD. To illustrate, in March 2022, Husch Blackwell, a conventional company in the US, began the Psychedelics and Emerging Therapies Practice Group to support innovators in studying, crafting, and marketing novel psychedelic-based therapies. This group consists of an integrated team of legal experts skilled in steering the intricate legal environment related to these substances, often categorized as Schedule I controlled substances under U.S. federal law, posing considerable regulatory obstacles that may impede research and development initiatives.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

Which Is The Largest Region In The Psychedelic Drugs Market?
North America was the largest region in the psychedelic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Psychedelic Drugs Market?
2. What is the CAGR expected in the Psychedelic Drugs Market?
3. What Are the Key Innovations Transforming the Psychedelic Drugs Industry?
4. Which Region Is Leading the Psychedelic Drugs Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Psychedelic Drugs Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities here

News-ID: 4015404 • Views:

More Releases from The Business Research Company

Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by 2029
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025? Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billion by 2029
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Rheology Modifiers Industry? There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analysis Report
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025? In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growth at 7.1% CAGR Forecast
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Pharmaceutical Intermediates Industry? There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound

All 5 Releases


More Releases for Psychedelic

Psychedelic Therapeutics Market in 2025 Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Psychedelic Therapeutics Market By Origin of Psychedelic Substance (Synthetic Substances and Natural Substances), Type of Psychedelic Substance (GHB, Ketamine, MDMA, Psilocybin, DMT, Ayahuasca and LSD), Target Therapeutic Area (Depression and Anxiety Disorders, Pain Disorders, Sleep-Related Disorders and Trauma)- Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic,
Ibogaine by David Dardashti Forges Strategic Partnership with Psychedelic Univer …
MIAMI, FL - June 20, 2025 - Ibogaine by David Dardashti, a pioneering leader in ibogaine-assisted therapy and led by visionary David Dardashti, today announced a groundbreaking collaboration with a Psychedelic University. This strategic partnership aims to establish robust internship opportunities for students passionate about contributing to the rapidly evolving psychedelic field, with initial networking prospects to be explored at the highly anticipated Psychedelic Conference 2025. The initiative is further
Psychedelic Drugs Market Growth, Status & Opportunities 2034
On March 21, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Psychedelic Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across
The Psychedelic Drugs Market: Exploring the Therapeutic Potential
The psychedelic drugs market is undergoing a significant resurgence, driven by a renewed interest in their potential therapeutic applications. After decades of legal restrictions and limited research, these substances are now being investigated for their potential to treat a range of mental health conditions, including depression, anxiety, post-traumatic stress disorder (PTSD), and addiction. This post will delve into the market, exploring its size, share, opportunities, challenges, demand, and trends. Market Size
Psychedelic Drugs Market Size, Overview & Leading 2024-2033
The new report published by The Business Research Company, titled ""Psychedelic Drugs Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the psychedelic drugs market size has grown rapidly in recent years. It will grow from $4.88 billion in
PSYCHEDELIC CHURCH SOUL TRIBES INTERNATIONAL MINISTRIES PRESENTS "SHROOM BREATH …
PSYCHEDELIC CHURCH SOUL TRIBES INTERNATIONAL MINISTRIES PRESENTS "SHROOM BREATH 369" - A TRANSFORMATIONAL PSYCHEDELIC HEALING EXPERIENCE DETROIT, MICHIGAN -- Psychedelic Church Soul Tribes International Ministries ("Soul Tribes" or the "Organization"), a 508(c)(1)(a) non-profit dedicated to psychedelic therapy and spiritual healing, announces its upcoming event, "Shroom Breath 369," on February 3rd, 2024, at the esteemed St. Regis in Detroit, Michigan. Title: Shroom Breath 369 - A Psychedelic Healing Experience Date: February 3rd, 2024 Time: 6:00